Expression of human cytochrome P450 1A2 in Escherichia coli: A system for biotransformation and genotoxicity studies of chemical carcinogens

Mutagenesis

Volumn 13, Issue 3, 1998, Pages 263-269

  Kranendonk, M ^a,b   Mesquita, P ^a   Laires, A ^a,c   Vermeulen, N P E ^b   Rueff, J ^a  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; 2 AMINOANTHRACENE; AFLATOXIN B1; CARCINOGEN; CYTOCHROME P450; FLAVONE; HYBRID PROTEIN; MUTAGENIC AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE;

ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; ESCHERICHIA COLI K 12; GENE EXPRESSION; GENOTOXICITY; METABOLIC ACTIVATION; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; TECHNIQUE;

4-NITROQUINOLINE-1-OXIDE; AFLATOXIN B1; ANIMALS; ANTHRACENES; BENZO(A)PYRENE; BIOTRANSFORMATION; CARCINOGENS; CYTOCHROME P-450 CYP1A2; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MUTAGENICITY TESTS; QUINOLINES; RATS; RECOMBINANT FUSION PROTEINS;

ESCHERICHIA; ESCHERICHIA COLI; ESCHERICHIA COLI K12; PROKARYOTA;

EID: 0031748441     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/13.3.263     Document Type: Article

References (42)

1. Aoyama,T., Yamano.S., Guzellian,P.S., Gelboin,H.V. and Gonzalez,F.J. (1990) Five of 12 forms of vaccinia virus-expressed human hepatic CYP metabolically activate aflatoxin B1. Proc. Natl Acad. Sci. USA, 87, 4790-4793.
2. Bauer,S. and Shiloach,J. (1974) Maximal exponential growth rate and yield of E.coli obtainable in a bench-scale fermentor. Biotechnol. Bioengng, XVI, 933-941.
3. Bridges,J.W. and Hubbard,S.A. (1980) Problems in providing an appropriate drug metabolising system for short-term tests for carcinogens. In Williams,G.M., Kroes,R., Waaijers,H.W. and van de Poll,K.W. (eds), The Predictive Value of Short-term Screening Tests in Carcinogenicity Evaluation. Elsevier, Amsterdam, The Netherlands, pp. 69-88.
4. Browner,M.F., Rasor,P., Tugendreich,S. and Fletterick,R.J. (1991) Temperature-sensitive production of rabbit muscle glycogen phosphorylase in Escherichia coli. Protein Engng, 4, 351-357.
5. Chang,A.C.Y and Cohen,S.N. (1978) Construction and characterisation of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic plasmid. J. Bacteriol., 134, 1141-1156.
6. Chang,T.K.H., Gonzalez,F.J. and Waxman,D.J. (1994) Evaluation of triacetyloleandomycin, α-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochrome P450. Arch. Biochem. Biophys., 311, 437-442.
7. Crespi,C.L., Penman,B.W., Steimel,D.T, Gelboin,H.V. and Gonzalez,F.J. (1991) The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3. Carcinogenesis, 12, 355-359.
8. Eaton,D.L. and Gallagher,E.P. (1994) Mechanisms of aflatoxin carcinogenesis. Annu. Rev. Pharmacol. Toxicol., 34, 135-172.
9. Fisher,C.W., Caudle,D.L., Martin-Wixtrom,C., Quattrochi,L.C., Tukey,R.H., Waterman,M.R. and Estabrook,W.R. (1992) High-level expression of functional human cytochrome P450 1A2 in Escherichia coli. FASEB J., 6, 759-764.
10. Gallagher,E.P., Wienkers,L.C., Stapleton,P.L., Kunze,K.L. and Eaton,D.L. (1994) Role of human microsomal and human complementary DNA-expressed cytochrome P4501A2 and P4503A4 in the bioactivation of aflatoxin B1. Cancer Res., 54, 101-108.
11. Glatt,H.R. (1997) Bioactivation of mutagens via sulfation. FASEB J., 11, 314-321.
12. Goeptar,A.R., Scheerens,H. and Vermeulen,N.P.E. (1995) Oxygen and xenobiotic reductase activities of cytochrome P450. Crit. Rev. Toxicol., 25, 25-65.
13. Gonzalez,F.J. and Gelboin,H.V. (1994) Role of human cytochrome P450 in the metabolic activation of chemical carcinogens and toxins. Drug Chem. Rev., 26, 165-183.
14. Gonzalez,F.J. and Korzekwa,K.R. (1994) Cytochromes P450 expression systems. Annu. Rev. Pharmacol. Toxicol., 35, 369-90.
15. Gonzalez,F.J., Crespi,C.L. and Gelboin,H.V. (1991) cDNA-expressed human cytochrome P450's: a new age of molecular toxicology and human risk assessment. Mutat. Res., 247, 113-127.
16. Grant,D.M., Josephy,P.D., Lord,H.L. and Morrison,L.D. (1992) Salmonella typhimurium strains expressing human arylamine N-acetyltransferase: metabolism and mutagenic activation of aromatic amines. Cancer Res., 52, 3961-3964.
17. Guengerich,F.P. (1992) Metabolic activation of carcinogens. Pharmac. Ther., 54, 17-61.
18. Jenkins,C.M. and Waterman,M.R. (1994) Flavodoxin and NADPH-flavodoxin reductase from Escherichia coli support bovine cytochrome P45017 α-hydroxylase activities. J. Biol. Chem., 269, 27401-27408.
19. Josephy,D.P., Debruin,L.S., Lord,H.L., Oak,J.N., Evans,D.H., Guo,Z., Dong,M. and Guengerich,F.P. (1995) Bioactivation of aromatic amines by recombinant human cytochrome P4501A2 expressed in Ames tester strain bacteria: a substitute for activation by mammalian tissue preparations. Cancer Res., 55, 799-802.
20. Kadlubar,F.F., Butler,M.A., Kaderlick,K.R., Chou,H.C. and Lang,N.P. (1992) Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environ. Hlth Perspect., 98, 69-74.
21. Kranendonk,M., Ruas,M., Laires,A. and Rueff,J. (1994a) Isolation and prevalidation of an Escherichia coli tester strain for use in mechanistic and metabolic studies of genotoxins. Mutat. Res., 312, 99-109.
22. Kranendonk,M., Ruas,M., Laires,A. and Rueff,J. (1994b) Isolation and prevalidation of an Escherichia coli tester strain for genotoxins. In Lechner,M.C. (ed.), Cytochrome P450, Biochemistry, Biophysics and Molecular Biology. Jonny Libbey Eurotext, Paris, France, pp. 741-744.
23. Kranendonk,M., Pintado,F., Mesquita,P., Laires,A., Vermeulen,N.P.E. and Rueff,J. (1996) MX100, a new Escherichia coli tester strain for use in genotoxicity studies. Mutagenesis, 11, 327-333.
24. Kranendonk,M., Commandeur,J.N.M., Laires,A., Rueff,J. and Vermeulen,N.P.E. (1997) Characterisation of enzyme activities and cofactors involved in bioactivation and bioinactivation of chemical carcinogens in the tester strains Escherichia coli K12 MX100 and Salmonella typhimurium LT2 TA100. Mutagenesis, 12, 245-254.
25. Langenbach,R., Smith,P.B. and Crespi,C. (1992) Recombinant DNA approaches for the development of metabolic systems used in in vitro toxicology. Mutat. Res., 277, 251-275.
26. Langer,P.J., Shanabruch,W.G. and Walker,G.C. (1981) Functional organisation of plasmid pKM101. J. Bacteriol., 145, 1310-1316.
27. Langer,P.J., Perry,K.L. and Walker,G.C. (1985) Complementation of a pKM101 derivative that decreases resistance to UV killing but increases susceptibility to mutagenesis. Mutat. Res., 150, 147-158.
28. Maron,D.M. and Ames,B.N. (1983) Revised methods for Salmonella mutagenicity test. Mutat. Res., 113, 173-215.
29. Miles,J.S. and Wolf,C.R. (1991) Developments and perspectives on the role of cytochrome P450s in chemical carcinogens. Carcinogenesis, 12, 2195-2199.
30. Miller,E.C. and Miller,J.A. (1981) Searches for ultimate chemical carcinogens and their reaction with cellular macromolecules. Cancer, 47, 2327-2345.
31. Oda,Y., Yamazaki,H., Thier,R., Ketterer,B. Guengerich,F.P. and Shimada,T. (1996) A new Salmonella typhimurium NM5004 strain expressing rat glutathione S-transferase 5-5: use in detection of genotoxicity of dihaloalkanes using an SOS/umu test system. Carcinogenesis, 17, 297-302.
32. Porter,T.D. and Larson,J.R. (1991) Expression of mammalian P450s in Escherichia coli. Methods Enzymol. 206, 108-116.
33. Ramsdell,H.S. and Eaton,D.L. (1990) Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformation. Cancer Res., 50, 615-620.
34. Rueff,J. et al. (1996) Development and validation of alternative metabolic systems for mutagenicity testing in short-term assays. Mutat. Res., 353, 151-176.
35. Rutten,A.A.J.J.L., Falke,H.E., Catsburg,J.F., Topp,R., Blaauboer,B.J., van Holsteijn,I., Doorn,L. and van Leeuwen,F.X.R. (1987) Interlaboratory comparison of total cytochrome P-450 and protein determinations in rat liver microsomes. Arch. Toxicol., 61, 27-33.
36. Sambrook,J., Fritsch,T.F. and Maniatis,T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
37. Shet,M.S., Fisher,C.W. and Estabrook,W.R. (1995) Expression, purification and enzymatic properties of a recombinant fusion protein containing human P450 1A2 joined to NADPH-P450 reductase. In Proceedings of the ISSX Meeting, Seattle, WA, Vol. 8, p. 362 (abstract).
38. Shimada,T., Gillam,E.M.J., Sandhu,P., Guo,Z., Tukey,R.H. and Guengerich,F.P. (1994) Activation of procarcinogens by human cytochrome P450 enzymes expressed in Escherichia coli. Simplified bacterial systems for genotoxociry assays. Carcinogenesis, 15, 2523-2529.
39. Simula,T.P., Glancey,J.M. and Wolf,C.R. (1993) Human glutathione S-transferase-expressing Salmonella typhimurium tester strains to study the activation/detoxification of mutagenic compounds: studies with halogenated compounds, aromatic amines and aflatoxin B1. Carcinogenesis, 14, 1371-1376.
40. Stavric,B. (1994) Biological significance of trace levels of mutagenic heterocyclic aromatic amines in human diet: a critical review. Fd Chem. Toxicol., 32, 977-994.
41. Thier,R., Taylor,J.B., Pemble,S.E., Humphreys,G., Humphreys,W., Persmark,M., Ketterer,B. and Guengerich,P. (1993) Expression of mammalian glutathione S-transferase 5-5 in Salmonella typhimurium TA1538 leads to base-pair mutation upon exposure to dihalomethanes. Proc. Natl Acad. Sci. USA, 90, 8576-8580.
42. Waterman,M.R. (1994) Heterologous expression of mammalian P450 enzymes. Adv. Enzymol. Related Areas Mol. Biol., 68, 37-66.